Merck asks FDA for emergency approval of its antiviral COVID-19 pill

Posted on AllSides October 11th, 2021
From The Right

Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration for emergency approval of its COVID-19 pill after the experimental drug showed “compelling results” in clinical trials.

The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50 percent in a late-stage trial, according to data from a phase three clinical trial shared earlier this month.

“The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our...

Read full story

New York Post (News)

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
See full bias rating for New York Post (News)
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right